BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2020
View Archived Issues
Antibiotics affect oxycodone effects
Read More
Cabo as next annual shot?
Read More
FDA approves IND for Organicell Flow as treatment of SARS due to COVID-19
Read More
Positive preclinical data support IND application for CardiALLO therapy in heart failure
Read More
MGH reports progress in development of a novel gene-based COVID-19 vaccine
Read More
Pfizer presents phase II data for PF-06480605 in ulcerative colitis
Read More
RBN-2397: a first-in-class PARP-7 inhibitor with oral antitumor activity
Read More
Health Canada clears phase I trial of AC-1101 for vitiligo
Read More
Genentech reports phase Ib data for UTTR-1147A
Read More
First-in-human data for SDX-7320 in advanced refractory or late-stage solid tumors
Read More
Novel variant in the SLC6A3 gene is linked to PKDYS1 phenotype
Read More
Remdesivir receives Japanese approval for severe COVID-19
Read More
DEP irinotecan enters phase II testing after positive phase I data
Read More
Roche patents new antivirals for HBV infection
Read More
Sage Therapeutics discloses GABA-A receptor modulators
Read More
Abbisko Therapeutics identifies RORC agonists
Read More
FDA approves the initiation of phase II COVID-19 studies of PUL-042
Read More
Chinese researchers identify new TLR7 agonists
Read More
New adenosine A2B receptor antagonists patented by Leadxpro
Read More
Positive topline data presented from phase IIa study of HTD-1801 in NASH and T2DM
Read More
Ovid reports topline phase II data with OV-101 in fragile X syndrome
Read More
Evelo announces IND application to study EDP-1815 for COVID-19
Read More
Allocetra studied for COVID-19 in new phase II trial
Read More
Protagonist Therapeutics reports initial phase II data on PTG-300 in polycythemia vera
Read More
Bridge Biotherapeutics receives Korean IND clearance for BBT-176 in NSCLC
Read More
FDA clears mRNA-1273 vaccine against SARS-CoV-2 to enter phase II
Read More
PrecisionLife identifies 59 compounds based on assessment of sepsis risk genes in severe COVID-19
Read More